𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo splenic irradiation eradicates suppressor T-cells causing the regression and inhibition of established tumor

✍ Scribed by Warren E. Enker; Janet L. Jacobitz

Publisher
John Wiley and Sons
Year
1980
Tongue
French
Weight
625 KB
Volume
25
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Splenic irradiation has been employed in tumor‐bearing animals to eradicate non‐specific, spleen‐seeking suppressor T cells, and to inhibit established tumor growth. MC1315 tumor‐bearing BALB/c mice were treated with 400 R splenic irradiation. Untreated mice or mice receiving 400 R splenic irradiation plus reconstitution with syngeneic spleen cells served as controls. Statistically significant inhibition of tumor growth, regression of established lethal tumor, and the disappearance of suppressor cell activity from the spleens of tumor‐regressed mice were observed. Tumor growth inhibition was statistically significant at the p < 0.001 level. We postulate that non‐specific, spleen‐seeking, radiation‐sensitive suppressor T cells are in a large measure responsible for mediating progressive tumor growth. By taking advantage of their radiosensitivity and by exploiting their spleen‐seeking nature, we have achieved significant regression of established tumor in up to 50% of the animals treated. These findings lend further support to the role of suppressor cells in abrogating anti‐tumor immunity, and suggest that their manipulation may have potential implications for the design of human adjuvant therapy.

📜 SIMILAR VOLUMES

The cellular and molecular basis of the
The cellular and molecular basis of the Lyt-1+2− T cell-mediated tumor-eradicating mechanism in vivo
✍ Hiromi Fujiwara; Toshiyuki Hamaoka 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmac. Ther. 14 SOGAWA, K., GOTOH, O., KAWAJIRI, K. & FUJI-KURIYAMA, Y. (1984). Distinct organization of methylcholanthrene-and phenobarbital-inducible cytochrome P-450 genes in

Recombinant antibody toxins specific for
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo
✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e

Antisense abrogation of DENN expression
Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle
✍ Kah M. Lim; Wee S. Yeo; Vincent T. K. Chow 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 719 KB

We previously reported that messenger RNA expression of DENN (differentially expressed in normal and neoplastic cells) is considerably higher in cancer cell lines than in normal cells. In our present study, we established that certain cancer cell lines express conspicuously higher levels of the 2 DE

Overexpression of the dynein light chain
Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase
✍ Nageswara R. Pulipati; Qunyan Jin; Xin Liu; Baodong Sun; Yan Zhao; Manoj K. Pand 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 938 KB

## Abstract km23‐1 is a dynein light chain that was identified as a TGFβ receptor‐interacting protein. To investigate whether km23‐1 controls human ovarian carcinoma cell (HOCC) growth, we established a tet‐off inducible expression system in SKOV‐3 cells in which the expression of km23‐1 is induced